Anna Rehammar
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic significance of deep sequencing for analysis of measurable residual disease in acute myeloid leukemia with NPM1 mutation.
Journal: Leukemia & lymphoma
Published: March 31, 2025
SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
Journal: BMC cancer
Published: June 29, 2020
MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression.
Journal: PLoS genetics
Published: August 10, 2019
Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations.
Journal: The Journal of molecular diagnostics : JMD
Published: February 01, 2018
miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 18, 2017
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
Journal: European journal of haematology
Published: May 17, 2016
Strategies to improve usability and preserve accuracy in biological sequence databases.
Journal: Proteomics
Published: February 12, 2016
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes.
Journal: International journal of cancer
Published: June 30, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026